Search results
Memantine User Reviews & Ratings. Memantine has an average rating of 5.6 out of 10 from a total of 81 reviews on Drugs.com. 53% of reviewers reported a positive experience, while 33% reported a negative experience.
Find 8 user ratings and reviews for Memantine (Namenda) on WebMD including side effects and drug interactions, medication effectiveness, ease of use and satisfaction.
10 wrz 2020 · All four treatment regimens were well tolerated by most patients. Memantine was the best‐tolerated medication, followed by placebo and the combination of memantine plus donepezil. Donepezil was the least tolerable.
Memantine has an average rating of 5.0 out of 10 from a total of 52 reviews for the treatment of Alzheimer's Disease. 35% of reviewers reported a positive experience, while 44% reported a negative experience. Filter by condition.
13 mar 2018 · Memantine (MEM), an antagonist of extrasynaptic NMDAR, is currently used for the treatment of AD jointly with acetylcholinesterase inhibitors. It has been demonstrated that MEM preferentially prevents the excessive continuous extrasynaptic NMDAR disease activation and therefore prevents neuronal cell death induced by excitotoxicity without ...
2 mar 2007 · Memantine, an NMDA receptor antagonist has been found to be effective, both as monotherapy and in combination with donepezil, in the treatment of patients with moderate to severe stage AD.
Find 184 user ratings and reviews for Namenda Oral on WebMD including side effects and drug interactions, medication effectiveness, ease of use and satisfaction.
